These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 54220)

  • 21. Induction of lymphocyte-mediated cytotoxicity against allogeneic tumor cells by concanavalin A in vivo.
    Anaclerio A; Waterfield JD; Möller G
    J Immunol; 1974 Sep; 113(3):870-5. PubMed ID: 4413847
    [No Abstract]   [Full Text] [Related]  

  • 22. Characterization of alloimmunization-induced T lymphocytes reactive against AKR leukemia in vitro and correlation with graft-vs-leukemia activity in vivo.
    Truitt RL; Shih CY; Lefever AV; Tempelis LD; Andreani M; Bortin MM
    J Immunol; 1983 Oct; 131(4):2050-8. PubMed ID: 6194224
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cell-mediated immunity to Friend virus-induced leukemia. II. Characteristics of primary cell-mediated cytotoxic response.
    Ting CC; Rodgigues D; Bushar GS; Herberman RB
    J Immunol; 1976 Jan; 116(1):236-43. PubMed ID: 54387
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Macrophage-mediated in vitro sensitization of T-lymphocytes. I; Detection of murine leukemia virus-associated antigens.
    Treves AJ; Feldman M; Kaplan HS
    J Natl Cancer Inst; 1977 May; 58(5):1527-9. PubMed ID: 192905
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Localization of aggregated cell surface antigens of target cells bound to cytotoxic T lymphocytes.
    Berke G; Fishelson ZV
    J Exp Med; 1975 Oct; 142(4):1011-6. PubMed ID: 1080790
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro interaction between lymphocytes allogenic leukemic cells.
    Biasi G; Collavo D; Colombatti A; Chieco-Bianchi L
    Bibl Haematol; 1975 Oct; (43):34-6. PubMed ID: 134694
    [No Abstract]   [Full Text] [Related]  

  • 27. Suppressed development of cytotoxic lymphoid cells in tumor-immunized mice.
    Martin WJ; Wunderlich JR; Macdonald J
    Isr J Med Sci; 1973 Mar; 9(3):324-31. PubMed ID: 4710040
    [No Abstract]   [Full Text] [Related]  

  • 28. Spontaneous antilymphoma reaction of preleukaemic AKR mice is a non-T-cell killing.
    Gomard E; Leclerc JC; Levy JP
    Nature; 1974 Aug; 250(5468):671-3. PubMed ID: 4854374
    [No Abstract]   [Full Text] [Related]  

  • 29. Specificity of cytolytic T cells directed against AKR/Gross virus-induced syngeneic leukemias: antibodies directed against H-2K, but not against viral proteins, inhibit lysis.
    Green WR; Nowinski RC; Henney CS
    J Immunol; 1980 Aug; 125(2):647-55. PubMed ID: 6156211
    [No Abstract]   [Full Text] [Related]  

  • 30. Specificity of 51Cr-release cytotoxicity of lymphocytes immune to murine sarcoma virus.
    Herberman RB; Aoki T; Nunn M; Lavrin DH; Soares N; Gazdar A; Holden H; Chang KS
    J Natl Cancer Inst; 1974 Oct; 53(4):1103-11. PubMed ID: 4139276
    [No Abstract]   [Full Text] [Related]  

  • 31. Evidence for the suppression of the development of cytotoxic lymphoid cells in tumor immunized mice.
    Martin WJ; Esber E; Wunderlich JR
    Fed Proc; 1973 Feb; 32(2):173-9. PubMed ID: 4688656
    [No Abstract]   [Full Text] [Related]  

  • 32. Mechanisms of leukemogenesis. I. Generation of autoreactive lymphocytes in response to a murine leukemia virus.
    Schenk PJ; Howe ML
    J Immunol; 1979 May; 122(5):1874-80. PubMed ID: 221580
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Participation of soluble H-2 antigens in serological and cellular reactions].
    Pletneva TP; Kaulen DR; Khorobrykh VV; Kirkin AF; Kotomina IF
    Nauchnye Doki Vyss Shkoly Biol Nauki; 1979; (5):24-8. PubMed ID: 88233
    [No Abstract]   [Full Text] [Related]  

  • 34. Cell surface antigens of radiation leukemia virus-induced BALB/c leukemias defined by syngeneic cytotoxic T lymphocytes.
    Kaneko Y; Oettgen HF; Obata Y; Nakayama E
    Jpn J Cancer Res; 1989 Mar; 80(3):257-64. PubMed ID: 2542207
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Retention of significant antibody binding by surface antigens of feline leukemia cells (FLA) after fixation with formaldehyde and glutaraldehyde.
    Davis S; Boone CW; Radin R; Wade MJ; Kleiner G
    Immunol Commun; 1974; 3(2):189-96. PubMed ID: 4362771
    [No Abstract]   [Full Text] [Related]  

  • 36. Cell-mediated reaction against tumors induced by oncornaviruses. I. Kinetics and specificity of the immune response in murine sarcoma virus (MSV)-induced tumors and transplanted lymphomas.
    Leclerc JC; Gomard E; Levy JP
    Int J Cancer; 1972 Nov; 10(3):589-601. PubMed ID: 4128690
    [No Abstract]   [Full Text] [Related]  

  • 37. Production of tumor-specific antibody in the xenogeneic host: use of blocking antibody.
    Weiner RS; Hubbard JD; Mardiney MR
    J Natl Cancer Inst; 1972 Oct; 49(4):1063-70. PubMed ID: 4117316
    [No Abstract]   [Full Text] [Related]  

  • 38. Energy requirements of the binding and lytic steps of T lymphocyte-mediated cytolysis of leukemic cells in vitro.
    Berke G; Gabison D
    Eur J Immunol; 1975 Oct; 5(10):671-5. PubMed ID: 11993332
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Secondary cytotoxic response in vitro against Moloney lymphoma cells antigenically altered by drug treatment in vivo.
    Santoni A; Kinney Y; Goldin A
    J Natl Cancer Inst; 1978 Jan; 60(1):109-12. PubMed ID: 146746
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lymphocyte-mediated cytotoxicity against tumor cells. I. Con A activated cytotoxic effector cells exhibit immunological specificity.
    Waterfield JD; Waterfield EM; Möller G
    Cell Immunol; 1975 Jun; 17(2):392-404. PubMed ID: 805001
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.